HFNC
HFNC is an intervention with 26 clinical trials. Currently 3 active trials ongoing. Historical success rate of 81.3%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
76.5%
13 of 17 finished
23.5%
4 ended early
3
trials recruiting
26
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Impact on Mortality of a Strategy Including Continuous Positive Airway Pressure Plus High Flow Nasal Cannula Oxygen Therapy Versus High Flow Nasal Cannula Oxygen Therapy Alone in Patients With de Novo Acute Hypoxemic Respiratory Failure: a Prospective, Randomized Controlled Trial.
Noninvasive Technique and High Flow Nasal Oxygen in Respiratory Failure
The Acute Respiratory Intervention StudiEs in Africa (ARISE-AFRICA) Study
Treatment of Dyspnea in Do-not-intubate Patients
HFNC Versus SOT During EBUS
Clinical Trials (26)
Impact on Mortality of a Strategy Including Continuous Positive Airway Pressure Plus High Flow Nasal Cannula Oxygen Therapy Versus High Flow Nasal Cannula Oxygen Therapy Alone in Patients With de Novo Acute Hypoxemic Respiratory Failure: a Prospective, Randomized Controlled Trial.
Noninvasive Technique and High Flow Nasal Oxygen in Respiratory Failure
The Acute Respiratory Intervention StudiEs in Africa (ARISE-AFRICA) Study
Treatment of Dyspnea in Do-not-intubate Patients
HFNC Versus SOT During EBUS
Effects of High-flow Oxygen Therapy and Non-invasive Ventilation on Lung Volumes and on Upper Airway
Comparison Physiological Effects According to Preoxygenation Method Using EIT
High Flow Nasal Cannula in Children With Status Asthmaticus
Comparative Study on the Effectiveness, Comfort and Compliance of HFNC and Noninvasive Mechanical Ventilation BiPAP Mode in the Treatment of Hypoxemia Patients
The Physiologic Effect of the Flow Generated by High Flow Nasal Cannula in Mild Respiratory Failure
HFNC Versus Oxygen Face Mask on Postoperative Pulmonery Complications
HFNC and NIV for COVID-19 Complicated by Respiratory Failure
Comparison of High Flow Nasal Cannula Therapy to Nasal Oxygen as a Treatment for Obstructive Sleep Apnea in Infants
Assessment of End Expiratory Lung Volumes in Healthy Subjects Using High Flow Oxygen (Vapotherm®)
Postextubation Management in Patients at Risk for Extubation Failure
Helmet CPAP Versus HFNC in COVID-19
HFNC During Awake Craniotomy - Impact on Patient Comfort
HFNC vs NPPV After Early Extubation for Patients With COPD
The Physiological Effect of High Flow Oxygen Therapy
HFNC Alone or Associated With NIV for Immunocompromised Patients Admitted to ICU for Acute Respiratory Failure
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 26